Icon

ATROVENT HFA (nda021527)- (0.021MG/INH)

IPRATROPIUM BROMIDE BOEHRINGER INGELHEIM
0.021MG/INH
Yes No
2030-Jan-17 Expired
None None
None No
ATROVENT HFA is an anticholinergic indicated for the maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema
0 0 0
Total Other Developers 12
Drugs with Suitability No
0.021MG/INH ** ** Up - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.